Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
21-day cumulative irritation study of topical acne formulations on healthy back skin
2009-014550-14Phase 4Completed
- Sponsor
- Dow
- Start
- Aug 2009
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clindamycin phosphate + benzoyl peroxide, clindamycin + benzoyl peroxide, tretinoin, adapalene, sodium lauryl sulfate and 1 more in acne vulgaris (8 arms), sponsored by Dow. Primary endpoint: Clinical assessment of irritant potential. Started Aug 2009; status: completed.
02
Drugs
clindamycin phosphate + benzoyl peroxideclindamycin + benzoyl peroxidetretinoinadapalenesodium lauryl sulfate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on 2009-014550-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014550-14.